tradingkey.logo
tradingkey.logo
検索

Nuwellis Inc

NUWE
ウォッチリストに追加
3.150USD
+0.010+0.32%
終値 07/02, 13:00ET15分遅れの株価
5.31M時価総額
2.31直近12ヶ月PER

詳細情報 Nuwellis Inc 企業名

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.

Nuwellis Incの企業情報

企業コードNUWE
会社名Nuwellis Inc
上場日Feb 16, 2012
最高経営責任者「CEO」Erb (John L)
従業員数38
証券種類Ordinary Share
決算期末Feb 16
本社所在地12988 Valley View Rd
都市EDEN PRAIRIE
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号55344
電話番号19523454200
ウェブサイトhttps://www.nuwellis.com/
企業コードNUWE
上場日Feb 16, 2012
最高経営責任者「CEO」Erb (John L)

Nuwellis Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--
Mr. David Alan (Dave) Mcdonald
Mr. David Alan (Dave) Mcdonald
Independent Director
Independent Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Gregory D. (Greg) Waller
Mr. Gregory D. (Greg) Waller
Independent Director
Independent Director
12.00
--
Dr. Archelle (Feldshon) Georgiou, M.D.
Dr. Archelle (Feldshon) Georgiou, M.D.
Independent Director
Independent Director
12.00
--
Erb (John L)
Erb (John L)
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
Chairman of the Board, President, Chief Executive Officer, Interim Chief Financial Officer, Interim Principal Financial Officer and Interim Principal Accounting Officer
--
-100.00%
Dr. Maria Rosa Costanzo, M.D.
Dr. Maria Rosa Costanzo, M.D.
Independent Director
Independent Director
--
--
Mr. Neil P. Ayotte, Esq.
Mr. Neil P. Ayotte, Esq.
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
Senior Vice President, General Counsel, Secretary and Chief Compliance Officer
--
--
Mr. Michael (Mike) Mccormick
Mr. Michael (Mike) Mccormick
Lead Independent Director
Lead Independent Director
--
--

よくある質問

Nuwellis Incの上位5名の株主は誰ですか?

Nuwellis Incの上位5名の株主は以下のとおりです。Mr. Gregory D. (Greg) Waller

Nuwellis Inc(NUWE)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Nuwellis Incの株式を保有している機関は20社あり、保有株式の総市場価値は約135.71Kで、全体の6.78%を占めています。2025Q4と比較して、機関の持ち株は58953.00増加しています。